Patents by Inventor Vikram Purohit

Vikram Purohit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150149334
    Abstract: A method includes identifying a plurality of functions performed by at least one of a sales division of an entity, a manufacturing division of the entity, or a supplier division of the entity during an intra-entity transaction by the at least one division. The method also includes determining, for each function of the plurality of functions, an allocation relationship based on an operating parameter of the at least one division, and determining, for each function, an intra-entity sales expense using the respective allocation relationship associated with each function. The method further includes providing, to the entity, an indication of net income and target earnings for the at least one division. The net income is provided for each function, and is determined based on the respective intra-entity sales expense associated with each function.
    Type: Application
    Filed: November 26, 2013
    Publication date: May 28, 2015
    Applicant: Thomson Reuters (Tax & Accounting) Services Inc.
    Inventors: Brian Tully, Pablo Perez Perez, Carl Philip Brandt, Enrico Valendiano Galvez, Vikram Purohit
  • Patent number: 8124794
    Abstract: The present invention features methods of treating a cancer in a subject by administering an effective amount of a beta-lactone to the subject. The invention also features methods of inhibiting angiogenesis in a subject by administering an effective amount of an inhibitor of fatty acid synthase to the subject. These methods can be used to treat a variety of cancers and other diseases and conditions. The invention also features methods of identifying beta-lactones and other compounds that can be used in the methods of the invention for the treatment of tumors, inhibition of angiogenesis, and the treatment of diseases and conditions that involve pathological angiogenesis. The invention also features methods of synthesizing beta-lactones and features novel beta-lactone compounds.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: February 28, 2012
    Assignee: Sanford-Burnham Medical Research Institute
    Inventors: Jeffrey W. Smith, Fumiko Axelrod, Steven J. Kridel, Daniel Romo, Vikram Purohit, Gil Ma
  • Publication number: 20100173982
    Abstract: The present invention features methods of treating a cancer in a subject by administering an effective amount of a beta-lactone to the subject. The invention also features methods of inhibiting angiogenesis in a subject by administering an effective amount of an inhibitor of fatty acid synthase to the subject. These methods can be used to treat a variety of cancers and other diseases and conditions. The invention also features methods of identifying beta-lactones and other compounds that can be used in the methods of the invention for the treatment of tumors, inhibition of angiogenesis, and the treatment of diseases and conditions that involve pathological angiogenesis. The invention also features methods of synthesizing beta-lactones and features novel beta-lactone compounds.
    Type: Application
    Filed: November 17, 2009
    Publication date: July 8, 2010
    Applicant: The Burnham Institute for Medical Research
    Inventors: Jeffrey W. Smith, Fumiko Axelrod, Steven J. Kridel, Daniel Romo, Vikram Purohit, Gil Ma
  • Patent number: 7728153
    Abstract: The present invention features methods of treating a cancer in a subject by administering an effective amount of a beta-lactone to the subject. The invention also features methods of inhibiting angiogenesis in a subject by administering an effective amount of an inhibitor of fatty acid synthase to the subject. These methods can be used to treat a variety of cancers and other diseases and conditions. The invention also features methods of identifying beta-lactones and other compounds that can be used in the methods of the invention for the treatment of tumors, inhibition of angiogenesis, and the treatment of diseases and conditions that involve pathological angiogenesis. The invention also features methods of synthesizing beta-lactones and features novel beta-lactone compounds.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: June 1, 2010
    Assignee: The Burnham Institute for Medical Research
    Inventors: Jeffrey W. Smith, Fumiko Axelrod, Steven J. Kridel, Daniel Romo, Vikram Purohit, Gil Ma
  • Publication number: 20070032657
    Abstract: A method of preparing an intermediate which is useful for the preparation of azaindole derivatives.
    Type: Application
    Filed: July 25, 2006
    Publication date: February 8, 2007
    Inventors: Prashant Deshpande, John Grosso, Apurba Bhattacharya, Vikram Purohit
  • Publication number: 20060258620
    Abstract: The present invention features methods of treating a cancer in a subject by administering an effective amount of a beta-lactone to the subject. The invention also features methods of inhibiting angiogenesis in a subject by administering an effective amount of an inhibitor of fatty acid synthase to the subject. These methods can be used to treat a variety of cancers and other diseases and conditions. The invention also features methods of identifying beta-lactones and other compounds that can be used in the methods of the invention for the treatment of tumors, inhibition of angiogenesis, and the treatment of diseases and conditions that involve pathological angiogenesis. The invention also features methods of synthesizing beta-lactones and features novel beta-lactone compounds.
    Type: Application
    Filed: March 16, 2006
    Publication date: November 16, 2006
    Applicant: Burnham Institute for Medical Research
    Inventors: Jeffrey Smith, Fumiko Axelrod, Steven Kridel, Daniel Romo, Vikram Purohit, Gil Ma